Advertisement
Advertisement

SVA

SVA logo

Sinovac Biotech, Ltd

6.47
USD
Sponsored
0.00
0.00%
Mar 28, 09:30 UTC -4
Closed
exchange

Pre-Market

6.47

0.00
0.00%

Sinovac Biotech, Ltd Profile

About

Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.

Info & Links

CEO

Weidong Yin

Headquarters

NO. 39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING, F4 100085, CHINA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.sinovac.com

Auditor

Marcum Bernstein & Pinchuk LLP

Share holders

--

Employees

4,275

Sinovac Biotech, Ltd Statistics

Valuation Measures

Market Capitalization2

388.59M

Enterprise Value

-3.32B

Enterprise Value/EBITDA(ttm)

-14.68

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.06

Price to Cash(ytd)

38.95

Profitability

Gross Margin(ttm)

65.40%

Operating Margin(ttm)

--

Profit Margin(ttm)

-1.67%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

18.42%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

442.91M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

385.27M

EBITDA(ttm)3

226.16M

Net Income Available to Common(ttm)

116.97M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.90

52-Week Change

--

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

86.89M

% Held by Insiders

12.79%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

9.94B

Total Cash Per Share(mrq)

--

Total Debt(mrq)

448.02M

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement